These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27686121)

  • 1. Design, synthesis, and evaluation of pyrazolo-pyrazole derivatives on Methylisocitratelyase of Pseudomonas aeruginosa: in silico and in vitro study.
    Pulaganti M; C M A; Kumar CS
    J Biomol Struct Dyn; 2017 Aug; 35(11):2509-2529. PubMed ID: 27686121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa.
    Dwivedi GR; Tyagi R; Sanchita ; Tripathi S; Pati S; Srivastava SK; Darokar MP; Sharma A
    J Biomol Struct Dyn; 2018 Dec; 36(16):4270-4284. PubMed ID: 29210342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of Chemical Compounds that Inhibit Leucyl-tRNA Synthetase from
    Zamacona R; Chavero PN; Medellin E; Hu Y; Hughes CA; Quach N; Keniry M; Bullard JM
    Curr Drug Discov Technol; 2020; 17(1):119-130. PubMed ID: 30088448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
    Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
    Skariyachan S; Parveen A; Garka S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.
    Hernandez V; Crépin T; Palencia A; Cusack S; Akama T; Baker SJ; Bu W; Feng L; Freund YR; Liu L; Meewan M; Mohan M; Mao W; Rock FL; Sexton H; Sheoran A; Zhang Y; Zhang YK; Zhou Y; Nieman JA; Anugula MR; Keramane el M; Savariraj K; Reddy DS; Sharma R; Subedi R; Singh R; O'Leary A; Simon NL; De Marsh PL; Mushtaq S; Warner M; Livermore DM; Alley MR; Plattner JJ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1394-403. PubMed ID: 23295920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual Screening of FDA-Approved Drugs against LasR of
    Sadiq S; Rana NF; Zahid MA; Zargaham MK; Tanweer T; Batool A; Naeem A; Nawaz A; Rizwan-Ur-Rehman ; Muneer Z; Siddiqi AR
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32824118
    [No Abstract]   [Full Text] [Related]  

  • 8. A Computational workflow for the identification of the potent inhibitor of type II secretion system traffic ATPase of Pseudomonas aeruginosa.
    Arifuzzaman M; Mitra S; Jahan SI; Jakaria M; Abeda T; Absar N; Dash R
    Comput Biol Chem; 2018 Oct; 76():191-201. PubMed ID: 30053700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Evaluation and Molecular Docking with In Silico Physicochemical, Pharmacokinetic and Toxicity Prediction of Pyrazolo[1,5-
    Naglah AM; Askar AA; Hassan AS; Khatab TK; Al-Omar MA; Bhat MA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32245177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Derivatives as
    Giorgini G; Mangiaterra G; Cedraro N; Laudadio E; Sabbatini G; Cantarini M; Minnelli C; Mobbili G; Frangipani E; Biavasco F; Galeazzi R
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Insights into Binding Mode and Interactions of Structure-Based Virtually Screened Inhibitors for
    Almihyawi RAH; Al-Hasani HMH; Jassim TS; Muhseen ZT; Zhang S; Chen G
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Inhibitors of Uridine Diphosphate-
    Acebrón-García-de-Eulate M; Mayol-Llinàs J; Holland MTO; Kim SY; Brown KP; Marchetti C; Hess J; Di Pietro O; Mendes V; Abell C; Floto RA; Coyne AG; Blundell TL
    J Med Chem; 2022 Feb; 65(3):2149-2173. PubMed ID: 35080396
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and Protein-Protein interaction network.
    Uddin R; Jamil F
    Comput Biol Chem; 2018 Jun; 74():115-122. PubMed ID: 29587180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virtual screening and antibacterial activity of lead compounds targeting to penicillin-binding protein 3 (PBP3) of Pseudomonas aeruginosa].
    Yu Z; Song L; Tong L; Wang Y; Zheng W; Gong X
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):219-31. PubMed ID: 27373070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Potential Inhibitor Targeting MurC Ligase of the Drug Resistant Pseudomonas aeruginosa Strain through Structure-Based Virtual Screening Approach and In Vitro Assay.
    Messaoudi A; Zoghlami M; Basharat Z; Sadfi-Zouaoui N
    Curr Pharm Biotechnol; 2019; 20(14):1203-1212. PubMed ID: 31333120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of N-aryl-glyoxamide derivatives as structurally novel bacterial quorum sensing inhibitors.
    Nizalapur S; Kimyon Ö; Biswas NN; Gardner CR; Griffith R; Rice SA; Manefield M; Willcox M; Black DS; Kumar N
    Org Biomol Chem; 2016 Jan; 14(2):680-693. PubMed ID: 26552577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.